Virica Biotech Revenue and Competitors

Ottawa, ON

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Virica Biotech's estimated annual revenue is currently $2.9M per year.(i)
  • Virica Biotech's estimated revenue per employee is $77,500

Employee Data

  • Virica Biotech has 38 Employees.(i)
  • Virica Biotech grew their employee count by -5% last year.

Virica Biotech's People

NameTitleEmail/Phone
1
Chief StaffReveal Email/Phone
2
Director, Commercial OperationsReveal Email/Phone
3
IT Technician Level 2Reveal Email/Phone
4
Laboratory TechnologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M9-72%$39.4MN/A
#2
$0.9M11-83%$23.8MN/A
#3
$87.6M5656%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$7.8M50-68%N/AN/A
#6
$13.5M8730%N/AN/A
#7
$17.8M115-6%N/AN/A
#8
$0.9M11-39%N/AN/A
#9
$13.6M88-20%$86MN/A
#10
$20M129-12%N/AN/A
Add Company

What Is Virica Biotech?

Cell + gene therapies and viral vaccines need higher yields. \nThat's our specialty. \nWe substantially increase yields by addressing the innate antiviral defences within production cells. These defences, designed to resist foreign genetic material and viral replication, work against your process. \n\nWe have developed a unique panel of small molecules (Viral Sensitizers) that turn off these antiviral responses in cells. \n\nWe first identified our novel Viral Sensitizers by employing an innovative high-throughput screening process. Virica continues to employ this cutting-edge equipment and can identify the most synergistic Viral Sensitizer molecules from our library for any virus or cell line. \n\nWe can tailor formulations of our Viral Sensitizers to boost virus yield in your manufacturing facility or improve the effects of your viral therapies.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$2.9M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.4M389%N/A
#2
$4.4M38N/AN/A
#3
$4.4M38-40%N/A
#4
$5.8M38-5%N/A
#5
$4.1M3911%N/A